NEW YORK (GenomeWeb) – Synthego — a Bay Area-based biotech startup aiming to automate and scale up genome engineering research — today announced it has raised $41 million in a Series B financing round.

AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities, ZhenFund, and University of California, Berkeley CRISPR researcher Jennifer Doudna joined the round as new investors, which was led by venture capital firm 8VC. Existing investors Founders Fund, Menlo Ventures, WI Harper Group, and SciFi VC also participated.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.